episode 66
Disrupting Drug Discovery and Development With AI
Data Science Leaders | 38:12 | February 15, 2024
Listen how you want
Get new episodes in your inbox
There is no such thing as an AI drug, but AI and ML-models are driving the next wave of new treatments. In this episode, Brandon Allgood, Chief Data Officer at FogPharma and serial entrepreneur at the intersection of ML and Biopharma, shares his insights on how AI is disrupting the traditional process of drug discovery and development.
Join us as we discuss:
- Why AI is so powerful for drug discovery
- What data science needs to learn from engineering
- How drug discovery processes need to be rebuilt with AI models at their core
Popular episodes
Featured Guest
Mike Gualtieri, VP and Principal Analyst at Forrester
James Cham
Partner, Bloomberg Beta
EPISODE 71April 11, 2024
Unlocking the disruptive potential of generative AI: a VC perspective
Listen Now | 28:49Volodimir Olexiouk
Director of Scientific Engagement and Data Science Team Lead, BioLizard
EPISODE 70March 28, 2024